SynthesisMedicine2020

Efficacy and safety of paclitaxel with or without targeted therapy as second-line therapy in advanced gastric cancer: A meta-analysis.

Ting Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.